Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05C HYPNOTICS AND SEDATIVES
N05CJ Orexin receptor antagonists
N05CJ01 Suvorexant
D10082 Suvorexant (JAN/USAN) <JP/US>
USP drug classification [BR:br08302]
Sleep Disorder Agents
Sleep Promoting Agents
Orexin Receptor Antagonists
Suvorexant
D10082 Suvorexant (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
119 Miscellaneous
1190 Miscellaneous
D10082 Suvorexant (JAN/USAN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG03225 Orexin receptor antagonist
D10082 Suvorexant
DG03202 Hypnotic
D10082 Suvorexant
Metabolizing enzyme substrate
DG01639 CYP2C19 substrate
D10082 Suvorexant
Transporter inhibitor
DG01622 ABCB1 inhibitor
D10082 Suvorexant
Drug classes [BR:br08332]
Neuropsychiatric agent
DG03202 Hypnotic
D10082 Suvorexant
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Orexin
HCRTR
D10082 Suvorexant (JAN/USAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10082
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D10082
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10082
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10082
Drug transporters
D10082